Roche
RO.SW
#41
Rank
NZ$563.79 B
Marketcap
NZ$708.63
Share price
-0.06%
Change (1 day)
35.04%
Change (1 year)

Roche (RO.SW) - Net assets

Net assets on the balance sheet as of December 2025 : NZ$80.51 Billion

According to Roche's latest financial reports the company has NZ$80.51 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Roche - Net assets on balance sheet (from 2006 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$NZ$82.61 B16.38%
2024-12-31$NZ$70.98 B13.47%
2023-12-31$NZ$62.56 B14.61%
2022-12-31$NZ$54.58 B20.18%
2021-12-31$NZ$45.41 B-27.36%
2020-12-31$NZ$62.52 B13.72%
2019-12-31$NZ$54.98 B19.46%
2018-12-31$NZ$46.02 B9.73%
2017-12-31$NZ$41.94 B12.11%
2016-12-31$NZ$37.41 B8.59%
2015-12-31$NZ$34.45 B23.8%
2014-12-31$NZ$27.83 B-4.47%
2013-12-31$NZ$29.13 B30.58%
2012-12-31$NZ$22.31 B12.61%
2011-12-31$NZ$19.81 B22.49%
2010-12-31$NZ$16.17 B29.07%
2009-12-31$NZ$12.53 B-85.91%
2008-12-31$NZ$88.93 B44.29%
2007-12-31$NZ$61.63 B12.84%
2006-12-31$NZ$54.61 B22.32%
2005-12-31$NZ$44.65 B9.18%
2004-12-31$NZ$40.89 B12.73%
2003-12-31$NZ$36.28 B-42.59%
2002-12-31$NZ$63.18 B-39.62%
2001-12-31$NZ$104.65 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
NZ$137.21 B 70.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$78.32 B-2.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$146.01 B 81.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$88.79 B 10.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.56 B-81.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$141.75 B 76.06%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$42.54 B-47.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$88.61 B 10.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$36.15 B-55.09%๐Ÿ‡ฌ๐Ÿ‡ง UK